Cefazolin Sodium recalls
Cefazolin Sodium products have been recalled 4 times, most recently on 15 Jun 2022. The recalling company is usually B. Braun Medical. The most common reason is manufacturing (cgmp) deviations.
Total recalls4since 2014
Last 12 months0reported
Class I250% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 50%Class II 2 50%Class III 0 0%
Why cefazolin sodium is recalled
Companies
Product types
By year
All cefazolin sodium recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Cefazolin for injection USP, and Dextrose Injection recalledCefazolin Sodium | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Cefazolin for injection USP, and Dextrose Injection recalledCefazolin Sodium | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS I | Cefazolin for Injection USP and Dextrose Injection recalledCefazolin Sodium | B. Braun Medical | Particulate Matter | Nationwide |
| Drug | CLASS I | Cefazolin for Injection USP and Dextrose Injections recalledCefazolin Sodium | B. Braun Medical | Particulate Matter | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.